News from the FDA/CDC

50.6 million tobacco users are not a homogeneous group


 

FROM MMWR

Cigarettes are still the product of choice among U.S. adults who use tobacco, but the youngest adults are more likely to use e-cigarettes than any other product, according to data from the 2019 National Health Interview Survey.

Percentage of adults who currently use tobacco products, 2019

Just under 21% of all adults (an estimated 50.6 million individuals) said they used tobacco products “every day” or “some days,” with cigarette use reported by the largest share of respondents (14.0%) and e-cigarettes next at 4.5%, Monica E. Cornelius, PhD, and associates said in the Morbidity and Mortality Weekly Report.

Among adults aged 18-24 years, however, e-cigarettes were used by 9.3% of respondents in 2019, compared with 8.0% who used cigarettes every day or some days. Current e-cigarette use was 6.4% in 25- to 44-year-olds and continued to diminish with increasing age, said Dr. Cornelius and associates at the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion.

Men were more likely than women to use e-cigarettes (5.5% vs. 3.5%), and to use any tobacco product (26.2% vs. 15.7%). Use of other products, including cigarettes (15.3% for men vs. 12.7% for women), followed the same pattern to varying degrees, the national survey data show.

“Differences in prevalence of tobacco use also were also seen across population groups, with higher prevalence among those with a [high school equivalency degree], American Indian/Alaska Natives, uninsured adults and adults with Medicaid, and [lesbian, gay, or bisexual] adults,” the investigators said.

Among those groups, overall tobacco use and cigarette use were highest in those with an equivalency degree (43.8%, 37.1%), while lesbian/gay/bisexual individuals had the highest prevalence of e-cigarette use at 11.5%, they reported.

“As part of a comprehensive approach” to reduce tobacco-related disease and death, Dr. Cornelius and associates suggested, “targeted interventions are also warranted to reach subpopulations with the highest prevalence of use, which might vary by tobacco product type.”

SOURCE: Cornelius ME et al. MMWR. 2020 Nov 20;69(46);1736-42.

Recommended Reading

Cancer disparities: One of the most pressing public health issues
Journal of Clinical Outcomes Management
The scope of under- and overtreatment in older adults with cancer
Journal of Clinical Outcomes Management
Apatinib plus gefitinib: Better PFS but more toxicity
Journal of Clinical Outcomes Management
High-dose TRT: A new standard of care for LS-SCLC?
Journal of Clinical Outcomes Management
FDA OKs combination immunotherapy for first-line mesothelioma treatment
Journal of Clinical Outcomes Management
National lung cancer screening guidelines may miss younger African American individuals at high risk
Journal of Clinical Outcomes Management
Real-world results with checkpoint inhibitors found inferior to trial results
Journal of Clinical Outcomes Management
New cancer drugs may have saved more than 1.2 million Americans
Journal of Clinical Outcomes Management
‘Test all patients with cancer’: One in eight have inherited mutations
Journal of Clinical Outcomes Management
Using telehealth to deliver palliative care to cancer patients
Journal of Clinical Outcomes Management